Michitaka Shichijo Selected Research

Michitaka Shichijo Research Topics

Disease

9	Allergic Rhinitis 12/2018 - 10/2002
6	Inflammation (Inflammations) 03/2019 - 09/2003
4	Asthma (Bronchial Asthma) 10/2015 - 10/2002
3	Eosinophilia 09/2011 - 04/2003
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2019 - 02/2014
2	Sneezing 05/2016 - 05/2016
2	Nasal Obstruction 05/2016 - 01/2008
2	Neoplasm Metastasis (Metastasis) 08/2014 - 06/2010
2	Atopic Dermatitis (Atopic Eczema) 07/2004 - 10/2002
1	Autoimmune Diseases (Autoimmune Disease) 03/2019
1	Immune System Diseases (Immune Disorders) 01/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2016
1	Respiratory Hypersensitivity 10/2015
1	Neoplasms (Cancer) 08/2014
1	Dermatitis 12/2013
1	Rhinitis 01/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2010
1	Contact Dermatitis (Eczema, Contact) 07/2004
1	Atherosclerosis 01/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2004
1	Lymphoma (Lymphomas) 11/2003
1	Edema (Dropsy) 09/2003
1	Hypersensitivity (Allergy) 09/2003
1	Anaphylaxis (Anaphylactic Shock) 09/2003

Drug/Important Bio-Agent (IBA)

5	AntigensIBA 01/2017 - 04/2003
5	Prostaglandin D2IBA 05/2016 - 11/2003
4	ProstaglandinsIBA 09/2011 - 04/2003
3	Prostaglandins DIBA 01/2012 - 04/2003
3	ramatrobanIBA 01/2004 - 04/2003
2	Interleukin-17 (Interleukin 17)IBA 03/2019 - 02/2014
2	InterleukinsIBA 03/2019 - 02/2014
2	OvalbuminIBA 05/2016 - 05/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 05/2016 - 01/2008
2	CytokinesIBA 02/2014 - 09/2011
2	7(2- (5- hydroxybenzo(b)thiophen- 3- ylcarbonylamino)- 10- norpinan- 3- yl)hept- 5- enoic acidIBA 09/2011 - 01/2008
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2004 - 11/2003
1	S18-000003IBA 03/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2019
1	AllergensIBA 12/2018
1	Complex MixturesIBA 05/2016
1	MucinsIBA 10/2015
1	asapiprantIBA 10/2015
1	human ERBB2 proteinIBA 08/2014
1	S-222611IBA 08/2014
1	ErbB Receptors (EGF Receptor)IBA 08/2014
1	Phosphotransferases (Kinase)IBA 08/2014
1	Interleukin-22 (IL-22)IBA 02/2014
1	Imiquimod (Aldara)FDA LinkGeneric 02/2014
1	LigandsIBA 02/2014
1	Interferon-alpha (Interferon Alfa)IBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	Transient Receptor Potential ChannelsIBA 12/2013
1	Drug CombinationsIBA 09/2011
1	Prednisolone (Predate)FDA LinkGeneric 09/2011
1	GlucocorticoidsIBA 09/2011
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 09/2011
1	Interleukin-2 (IL2)IBA 06/2010
1	Sorafenib (BAY 43-9006)FDA Link 06/2010
1	AcidsIBA 01/2008
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 01/2008
1	Chemotactic FactorsIBA 07/2004
1	Fluorescein-5-isothiocyanate (FITC)IBA 07/2004
1	ChemokinesIBA 07/2004
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2004
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2004
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2004
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 11/2003
1	CalciumIBA 11/2003
1	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2003
1	Syk KinaseIBA 09/2003
1	2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA 09/2003
1	ThromboxanesIBA 04/2003
1	IgE Receptors (Fc epsilon RI)IBA 10/2002
1	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2002

Therapy/Procedure

5	Therapeutics 08/2014 - 10/2002
1	Topical Administration 03/2019
1	Ligation 07/2004
1	Oral Administration 09/2003
1	Intranasal Administration 04/2003